Regulatory & Legal

Australian biotech Amplia Therapeutics is bringing its promising pancreatic cancer trial to the US, a key step in developing a drug that targets the disease's defenses.

The CRA has eliminated wait times for tax preparer access, but it means a major procedural shift for professionals. Here’s what you need to know.

Amidst a wave of new global regulations, Choice Cyber Solutions formalizes its leadership, positioning itself for growth and enhanced client compliance.

M&T Bank earns top honors for business banking, but its success reveals a deeper story about blending community trust with digital power in a competitive era.

New partnerships expand Cadence's remote patient care, using data to slash hospital visits, cut costs, and empower seniors to live healthier at home.

Social Commerce Partners Corp. begins separate trading for its shares and warrants, a key step as it navigates a tough market to find a target in direct selling.

MoonPay's new 'Deposits' feature simplifies complex crypto transfers, aiming to bring over 100 million Telegram users into the TON ecosystem seamlessly.

Award-winning firm Work Program Architects opens a Raleigh office, aiming to tackle North Carolina's growth and climate challenges with community-first design.

As governments mandate a shift to post-quantum cryptography, a new chip offers a hardware-based solution to secure everything from cars to national defense.

The tax giant is betting big on the $250B creator economy with a new platform. Can it solve the financial chaos plaguing today's digital entrepreneurs?

UCLA's Dr. Donald Kohn joins the Jeffrey Modell Foundation to discuss revolutionary gene therapies offering new hope for Primary Immunodeficiency patients.

Insight Molecular Diagnostics secures $26M to expand its transplant rejection test to the heart market, backed by a major shareholder amid market dilution concerns.

A new social commerce platform lets you earn company equity by shopping for Nike and Adidas. Can it change how we shop and keep our fitness goals?

A new partnership with Uniphar will use managed access programs to provide the lymphoma therapy LYMPHIR to European patients with limited treatment options.

Sphinx Investment extends its takeover offer for Performance Shipping again, marking a nearly three-year saga of corporate warfare and shareholder uncertainty.

Aveanna Healthcare's Heartways program earns a top national certification, signaling a major shift in managing America's costliest disease from home.

Daré Bioscience launches telehealth for DARE to PLAY™, the first evidence-backed topical sildenafil cream designed to address female sexual arousal.

With a new finance chief and an expanded Austin base, Outdoorsy Group is pivoting its travel tech empire to power the coming age of autonomous mobility.

With major conferences ahead, clinical-stage MBX Biosciences aims to impress investors with its promising peptide therapies for endocrine and metabolic disorders.

Abaxx's new wind futures for the Netherlands, France, and Spain aim to provide critical financial tools to stabilize renewable energy revenue streams.